Mirum Pharmaceuticals, Inc. (MIRM)
MIRM price $83.32 -1.75 -2.06%
- Ticker
- MIRM
- Price
- $83.32
- Change
- -1.75 -2.06%
- Market cap
- $5.41B
- P/E
- -5.84
- Forward P/E
- 39.54
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 66
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address…